U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Controlled release succinic acid microcapsules coated with aqueous acrylics

Patent 5395628 Issued on March 7, 1995. Estimated Expiration Date: Icon_subject April 13, 2012. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

Dipyridamole-containing pharmaceutical form
Patent #: 4427648
Issued on: 01/24/1984
Inventor: Brickl ,   et al.

Aqueous coating dispersions
Patent #: 4737357
Issued on: 04/12/1988
Inventor: Lehmann ,   et al.

Sustained absorption pharmaceutical composition
Patent #: 4820521
Issued on: 04/11/1989
Inventor: Panoz ,   et al.

Controlled release powder and process for its preparation Patent #: 4940588
Issued on: 07/10/1990
Inventor: Sparks, et al.

Inventors

Assignee

Application

No. 870195 filed on 04/13/1992

US Classes:

424/490, Coated (e.g., microcapsules)424/468, Sustained or differential release type424/474, Coated pills or tablets424/487Acrylic acid and derivatives

Examiners

Primary: Page, Thurman K.
Assistant: Levy, Neil S.

Attorney, Agent or Firm

Foreign Patent References

  • 0122077 EP. 10/12/1984
  • 0156077 EP. 10/12/1985
  • 0156243 EP. 10/12/1985
  • 0181515 EP. 05/12/1986
  • 0225085 EP. 06/12/1987
  • 0262422 EP. 08/12/1987
  • 88/03795 WO. 06/12/1988

International Class

A61K 009/50

Foreign Application Priority Data

1989-12-28 JP

Abstract

A controlled release pharmaceutical preparation comprising (a) a core containing a pharmaceutically active substance and an organic acid, and (b) a coating film formed on the surface of the core by aqueous coating of a water-insoluble and water-slightly permeable acrylic polymer containing a trimethylammonium-ethyl group, which exhibits well controlled dissolution and release of the pharmaceutically active substance when administered and can maintain the desired blood level of the active substance for a long period of time, and a method for producing the preparation.

Other References

  • Documentation from Rohm Pharma, "EUDRAGIT.RTM. RL/RS-Dispersionen"; Vorlaufiges Merkblatt
  • Documentation from Rohm Pharma GmbH Co., "Eudragit RL30D and RS30D: Aqueous Acrylic Resin Dispersion-Application in the Production of Pharmaceutical Preparations", Prospectus (Infor RL/RSD-1/e), pp. 1-7
  • R. S. Okor, W. Anderson, "Communications: Casting solvent effects on the permeability of polymer films of differing quaternary ammonium (cation) content", J. Pharm. Pharmacol, (1987) 39, pp. 547-54
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$18.95more info
 
Sign InRegister
Username  
Password   
forgot password?